Nika Pharmaceuticals, Inc. Stock Price

OTCPK:NIKA Community·US$395.2m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

NIKA Share Price Performance

US$0.38

-0.21 (-35.58%)

US$0.38

-0.21 (-35.58%)

US$0.38

Fri, 2 Jan 26

Share Pricen/a

NIKA Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Slight risk with weak fundamentals.

4 Risks

1 Reward

View Full Analysis

Nika Pharmaceuticals, Inc. Key Details

Last Reported Earnings

Sep 30, 2025

Next Reporting Earnings

n/a

: -0.00005
: 0%
: 0%
: -109.1%

View Full Analysis

About NIKA

Founded: 2000
Employees: n/a
CEO: Dimitar Savov
WebsiteView website: www.nikapharmaceuticals.com

Nika Pharmaceuticals, Inc., a pharmaceutical company, develops drugs for the treatment of HIV/AIDS, hepatitis B and C, rheumatoid arthritis, cancer, diabetes, and various other diseases. It offers dietary supplements and antiviral drugs, as well as thymus nuclear glycoprotein for the treatment of HIV. The company was formerly known as Centennial Growth Equities Inc. and changed its name to Nika Pharmaceuticals, Inc. in May 2022. Nika Pharmaceuticals, Inc. was incorporated in 2000 and is based in Henderson, Nevada.